New hope for women with severe vulvar skin disease: methotrexate trial launches
NCT ID NCT07352917
First seen Jan 24, 2026 · Last updated May 25, 2026 · Updated 23 times
Summary
This study tests if methotrexate, an immune-modulating drug, can help women with severe vulvar lichen sclerosus who did not get better with standard steroid creams. Twelve women will receive weekly injections for 12 months. The goal is to see if symptoms and skin changes improve, and if the treatment is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVAR LICHEN SCLEROSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DermoCentro
RECRUITINGSão José dos Campos, São Paulo, 12245760, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.